vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and TENNANT CO (TNC). Click either name above to swap in a different company.
TENNANT CO is the larger business by last-quarter revenue ($291.6M vs $185.2M, roughly 1.6× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -1.5%, a 2.4% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -11.3%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $9.7M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -3.2%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
The Tennant Company (TNC:NYQ) is a company with about 4000 employees that provides cleaning products. It is a company that is listed in the New York Stock Exchange.
FOLD vs TNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $291.6M |
| Net Profit | $1.7M | $-4.4M |
| Gross Margin | 85.7% | 34.6% |
| Operating Margin | 8.6% | -1.4% |
| Net Margin | 0.9% | -1.5% |
| Revenue YoY | 23.7% | -11.3% |
| Net Profit YoY | -88.5% | -166.7% |
| EPS (diluted) | $0.00 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $291.6M | ||
| Q3 25 | $169.1M | $303.3M | ||
| Q2 25 | $154.7M | $318.6M | ||
| Q1 25 | $125.2M | $290.0M | ||
| Q4 24 | $149.7M | $328.9M | ||
| Q3 24 | $141.5M | $315.8M | ||
| Q2 24 | $126.7M | $331.0M | ||
| Q1 24 | $110.4M | $311.0M |
| Q4 25 | $1.7M | $-4.4M | ||
| Q3 25 | $17.3M | $14.9M | ||
| Q2 25 | $-24.4M | $20.2M | ||
| Q1 25 | $-21.7M | $13.1M | ||
| Q4 24 | $14.7M | $6.6M | ||
| Q3 24 | $-6.7M | $20.8M | ||
| Q2 24 | $-15.7M | $27.9M | ||
| Q1 24 | $-48.4M | $28.4M |
| Q4 25 | 85.7% | 34.6% | ||
| Q3 25 | 88.5% | 42.7% | ||
| Q2 25 | 90.2% | 42.1% | ||
| Q1 25 | 90.7% | 41.4% | ||
| Q4 24 | 90.1% | 41.3% | ||
| Q3 24 | 90.6% | 42.4% | ||
| Q2 24 | 91.1% | 43.1% | ||
| Q1 24 | 87.7% | 44.2% |
| Q4 25 | 8.6% | -1.4% | ||
| Q3 25 | 20.3% | 7.4% | ||
| Q2 25 | -6.1% | 9.6% | ||
| Q1 25 | -6.3% | 6.8% | ||
| Q4 24 | 10.7% | 2.3% | ||
| Q3 24 | 15.3% | 9.7% | ||
| Q2 24 | 11.8% | 11.7% | ||
| Q1 24 | -25.1% | 12.1% |
| Q4 25 | 0.9% | -1.5% | ||
| Q3 25 | 10.2% | 4.9% | ||
| Q2 25 | -15.8% | 6.3% | ||
| Q1 25 | -17.3% | 4.5% | ||
| Q4 24 | 9.8% | 2.0% | ||
| Q3 24 | -4.8% | 6.6% | ||
| Q2 24 | -12.4% | 8.4% | ||
| Q1 24 | -43.9% | 9.1% |
| Q4 25 | $0.00 | $-0.21 | ||
| Q3 25 | $0.06 | $0.80 | ||
| Q2 25 | $-0.08 | $1.08 | ||
| Q1 25 | $-0.07 | $0.69 | ||
| Q4 24 | $0.05 | $0.35 | ||
| Q3 24 | $-0.02 | $1.09 | ||
| Q2 24 | $-0.05 | $1.45 | ||
| Q1 24 | $-0.16 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | — |
| Total DebtLower is stronger | $392.7M | $273.2M |
| Stockholders' EquityBook value | $274.2M | $601.6M |
| Total Assets | $949.9M | $1.3B |
| Debt / EquityLower = less leverage | 1.43× | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | — | ||
| Q3 25 | $263.8M | — | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $250.6M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $249.8M | — | ||
| Q2 24 | $260.1M | — | ||
| Q1 24 | $239.6M | — |
| Q4 25 | $392.7M | $273.2M | ||
| Q3 25 | $392.0M | $238.3M | ||
| Q2 25 | $391.3M | $213.4M | ||
| Q1 25 | $390.7M | $213.3M | ||
| Q4 24 | $390.1M | $198.2M | ||
| Q3 24 | $389.5M | $208.6M | ||
| Q2 24 | $388.9M | $205.6M | ||
| Q1 24 | $388.4M | $207.4M |
| Q4 25 | $274.2M | $601.6M | ||
| Q3 25 | $230.4M | $640.9M | ||
| Q2 25 | $204.3M | $651.9M | ||
| Q1 25 | $193.6M | $624.4M | ||
| Q4 24 | $194.0M | $620.8M | ||
| Q3 24 | $178.8M | $647.2M | ||
| Q2 24 | $132.5M | $624.6M | ||
| Q1 24 | $130.7M | $614.6M |
| Q4 25 | $949.9M | $1.3B | ||
| Q3 25 | $868.8M | $1.3B | ||
| Q2 25 | $815.3M | $1.2B | ||
| Q1 25 | $789.8M | $1.2B | ||
| Q4 24 | $785.0M | $1.2B | ||
| Q3 24 | $786.6M | $1.2B | ||
| Q2 24 | $749.5M | $1.2B | ||
| Q1 24 | $721.8M | $1.2B |
| Q4 25 | 1.43× | 0.45× | ||
| Q3 25 | 1.70× | 0.37× | ||
| Q2 25 | 1.92× | 0.33× | ||
| Q1 25 | 2.02× | 0.34× | ||
| Q4 24 | 2.01× | 0.32× | ||
| Q3 24 | 2.18× | 0.32× | ||
| Q2 24 | 2.93× | 0.33× | ||
| Q1 24 | 2.97× | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $14.2M |
| Free Cash FlowOCF − Capex | $16.0M | $9.7M |
| FCF MarginFCF / Revenue | 8.6% | 3.3% |
| Capex IntensityCapex / Revenue | 0.2% | 1.5% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $14.2M | ||
| Q3 25 | $35.7M | $28.7M | ||
| Q2 25 | $-26.5M | $22.5M | ||
| Q1 25 | $7.8M | $-400.0K | ||
| Q4 24 | $-3.9M | $37.5M | ||
| Q3 24 | $-23.0M | $30.7M | ||
| Q2 24 | $22.7M | $18.6M | ||
| Q1 24 | $-29.7M | $2.9M |
| Q4 25 | $16.0M | $9.7M | ||
| Q3 25 | $35.3M | $22.3M | ||
| Q2 25 | $-28.9M | $18.7M | ||
| Q1 25 | $7.5M | $-7.4M | ||
| Q4 24 | $-4.2M | $28.1M | ||
| Q3 24 | $-23.3M | $26.4M | ||
| Q2 24 | $21.6M | $14.4M | ||
| Q1 24 | $-31.5M | $-100.0K |
| Q4 25 | 8.6% | 3.3% | ||
| Q3 25 | 20.9% | 7.4% | ||
| Q2 25 | -18.7% | 5.9% | ||
| Q1 25 | 6.0% | -2.6% | ||
| Q4 24 | -2.8% | 8.5% | ||
| Q3 24 | -16.5% | 8.4% | ||
| Q2 24 | 17.0% | 4.4% | ||
| Q1 24 | -28.5% | -0.0% |
| Q4 25 | 0.2% | 1.5% | ||
| Q3 25 | 0.2% | 2.1% | ||
| Q2 25 | 1.6% | 1.2% | ||
| Q1 25 | 0.2% | 2.4% | ||
| Q4 24 | 0.2% | 2.9% | ||
| Q3 24 | 0.3% | 1.4% | ||
| Q2 24 | 0.9% | 1.3% | ||
| Q1 24 | 1.6% | 1.0% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | 1.93× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | -0.27× | 5.68× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | 0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
TNC
| Equipment Sales | $165.5M | 57% |
| Parts And Consumables | $69.1M | 24% |
| Service And Other | $57.0M | 20% |
